Jupiter Topco LLC Acquires New Shares in Corteva, Inc. $CTVA

Jupiter Topco LLC acquired a new position in shares of Corteva, Inc. (NYSE:CTVA) in the second quarter, HoldingsChannel.com reports. The firm acquired 6,426,384 shares of the company’s stock, valued at approximately $544,246,000.

Other hedge funds also recently added to or reduced their stakes in the company. EFG International AG bought a new stake in Corteva in the 2nd quarter valued at about $25,000. Compass Financial Management LLC bought a new position in Corteva in the 2nd quarter worth about $25,000. Elevation Wealth Partners LLC increased its stake in shares of Corteva by 334.6% in the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after purchasing an additional 261 shares during the period. Clearstead Trust LLC acquired a new stake in shares of Corteva in the second quarter valued at approximately $31,000. Finally, JPL Wealth Management LLC bought a new stake in shares of Corteva during the third quarter valued at approximately $25,000. 81.54% of the stock is currently owned by institutional investors.

Corteva Stock Performance

CTVA opened at $83.18 on Wednesday. The business has a 50 day moving average price of $82.39 and a two-hundred day moving average price of $80.37. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. The company has a market capitalization of $55.50 billion, a price-to-earnings ratio of 55.09, a price-to-earnings-growth ratio of 2.54 and a beta of 0.57. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $90.97.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. During the same period last year, the firm earned $2.20 EPS. The firm’s revenue for the quarter was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Research analysts predict that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva’s payout ratio is presently 47.68%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on CTVA shares. Mizuho increased their price objective on Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a report on Tuesday, July 14th. Rothschild & Co Redburn increased their price target on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 29th. Jefferies Financial Group increased their price target on Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. Royal Bank Of Canada lifted their price objective on shares of Corteva from $97.00 to $103.00 and gave the company an “outperform” rating in a research note on Tuesday, July 21st. Finally, UBS Group reduced their price objective on shares of Corteva from $89.00 to $85.00 and set a “neutral” rating for the company in a report on Tuesday, August 18th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Corteva has an average rating of “Moderate Buy” and an average target price of $91.50.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.